Navigation Links
PDL BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance
Date:3/2/2010

ceives a flat three percent royalty as compared to the tiered royalty that it receives from Genentech for product sales that are either manufactured or sold in the United States.  As a percent of total Herceptin sales, ex-U.S. manufactured and sold Herceptin increased to 43 percent from 16 percent for the same period in the prior year. Ex-U.S. manufactured and sold Avastin sales represented five percent of total Avastin sales. This is the first quarter in which PDL has received royalties on sales of ex-U.S. manufactured and sold Avastin.

Reported sales of Lucentis increased 64 percent when compared to the same period for the prior year.  Ex-U.S. sales of Lucentis, which is approved in more than 80 countries worldwide, increased 88 percent when compared to the same period for the prior year and represented 57 percent of total global sales.

Reported sales of Tysabri increased 32 percent when compared to the same period for the prior year.  Ex-U.S. sales of Tysabri increased 42 percent when compared to the same period for the prior year, and represented 53 percent of total global sales.   Elan recently reported a 30 percent increase in the worldwide Tysabri patient population at the end of December 2009 as compared with December 2008.

'/>"/>
SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
2. Indiana Biopharmaceutical Service Providers Maintain Steady Growth Despite Industry Challenges
3. SynCo Bio Partners Signs New Manufacturing Agreements to Supply the US Market; Securing its Position as a Market Leader in Microbial Biopharmaceutical Contract Production
4. ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency Achieved by Biopharmaceutical Companies at European Outsourcing Event
5. Sinobiopharma Announces Second Quarter 2010 Financial Results
6. Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry
7. YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract
8. Array BioPharma and Amgen Partner in Type 2 Diabetes
9. PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million
10. PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend
11. PDL BioPharma Announces Special Dividend Payment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Dr. Greg Leyer of ... annual Scripps Natural Supplements Pre-Conference seminar on probiotics in San ... an annual continuing education conference for health care professionals. This ... the topic of probiotics in health. Dr. Leyer spoke about ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Diagenode, ... such as the Bioruptor® and complete solutions for ... for chromatin immunoprecipitation, alleviating the need for manual ... controls needed for ChIP of histones or transcription ...
(Date:1/22/2015)... 2015  Varian Medical Systems (NYSE: VAR ), world ... its commitment to sustainability with inclusion on a prestigious list ... ranked healthcare equipment company among the Corporate Knights Global 100 ... Forum at Davos, Switzerland . ...
(Date:12/25/2014)... 25, 2014 The report “Service Quality ... Type & Provider Type - Global Advancements, Worldwide Forecasts ... an in-depth analysis and forecasting of revenues. , ... 221 pages and in-depth TOC on “Service Quality Management ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Varian Honored Among World's 100 Most Sustainable Corporations 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4
... TORONTO, Sept. 15, 2011 Generex Biotechnology Corporation ... update on the status of the previously announced ... ( www.antigenexpress.com ). The Company is ... review of several transaction opportunities, including both shell ...
... and SYDNEY, Sept. 14, 2011 HeartWare International, Inc. ... leading innovator of less invasive, miniaturized circulatory support technologies ... today announced that CEO Doug Godshall is scheduled to ... 10:30 a.m. ET on Wednesday, September 21, 2011.  The ...
... 2011 Tengion, Inc. (NASDAQ: TNGN ), a ... President Finance and Chief Financial Officer of Tengion, will present ... September 19, 2011, at 1:30 pm EDT. ... "Calendar of Events" in the Investors section of the Company,s ...
Cached Biology Technology:Generex Provides Update on Spinout of Antigen Express 2Generex Provides Update on Spinout of Antigen Express 3Generex Provides Update on Spinout of Antigen Express 4HeartWare to Present at the UBS Global Life Sciences Conference 2Tengion to Present at UBS Global Life Sciences Conference 2
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
(Date:1/22/2015)... Issued by Small Cap IR. In 2011, Nilson Report,s annual ... merchants on the leading payment cards rose to $135.3 billion ... prepaid cards reached 6.54 billion.  Eight million credit card users ... 2012, and credit and debit card fraud resulted in $11.27 ...
(Date:1/22/2015)... NEW YORK , Jan. 22, 2015   EyeLock, Inc. ... announced it has appointed Steve Gerber to the ... Gerber will be responsible for leading development of mobile platforms ... 25 years of success and innovation in the semiconductor industry ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... January 11, 2010 The subtle but ongoing pressures of ... as autism, autoimmune diseases, and reproductive cancers, researchers write in ... Certain adaptations that once benefited humans may now be ... because of advancements in modern culture and medicine. ...
... , REDWOOD CITY, Calif. and ... in fingerprint identity and authentication solutions, has extended its ... Retail Anywhere , a leading developer of point-of-sale (POS) ... in North America, has integrated U.are.U® fingerprint ...
... significantly enhance household incomes and nutritional intake of ... new Stanford University study published in the Proceedings ... two-year study found that solar-powered pumps installed in ... Benin were a cost-effective way of delivering much-needed ...
Cached Biology News:Ongoing human evolution could explain recent rise in certain disorders 2Retail Anywhere Adds U.are.U Biometrics From DigitalPersona to Flagship Point of Sale Solution 2Retail Anywhere Adds U.are.U Biometrics From DigitalPersona to Flagship Point of Sale Solution 3Solar-powered irrigation significantly improves diet and income in rural sub-Saharan Africa 2Solar-powered irrigation significantly improves diet and income in rural sub-Saharan Africa 3Solar-powered irrigation significantly improves diet and income in rural sub-Saharan Africa 4
...
... (patent pending) was developed using a protein engineering ... DNA binding pocket of wild-type DNase I. These ... for DNA. The result is a versatile enzyme ... and an ability to maintain at least 50% ...
... is an antibody-mediated hot-start DNA ... and real-time PCR applications. The ... concentration of 5 units per ... polymerase, 1.25 ml 10x PCR ...
hnRNP U (H-94)...
Biology Products: